Literature DB >> 9275307

Anandamide and other N-acylethanolamines in mouse peritoneal macrophages.

P C Schmid1, T Kuwae, R J Krebsbach, H H Schmid.   

Abstract

N-acyl phosphatidylethanolamine (N-acyl PE) and free N-acylethanolamine (NAE) in mouse peritoneal macrophages were identified and quantified by gas chromatography-mass spectrometry (GC-MS) of tertbutyldimethylsilyl derivatives in the presence of internal standards synthesized from [1,1,2,2-2H4]ethanolamine. N-acyl PE was present at a level of 123-187 pmol/mumol lipid P (521-768 pmol/10(8) cells), with arachidonic acid making up about 3-4% of the N-acyl moieties. NAE, on the other hand, was present at a level of only 17-30 pmol/mumol lipid P (70-121 pmol/10(8) cells), with N-arachidonoylethanolamine (anandamide) making up less than 1% of total NAE. Use of deuterium labeled internal standards and optimization of GC-MS conditions makes it possible to detect as little as 0.1 ng of saturated and 1 ng (3 pmol) of polyunsaturated NAEs in a lipid extract. The present method can be used to determine agonist-induced changes in the levels and compositions of N-acyl PE and NAE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275307     DOI: 10.1016/s0009-3084(97)00032-7

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  12 in total

Review 1.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

2.  Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.

Authors:  R Capasso; A A Izzo; F Fezza; A Pinto; F Capasso; N Mascolo; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.

Authors:  Yasuo Okamoto; Jun Morishita; Jun Wang; Patricia C Schmid; Randy J Krebsbach; Harald H O Schmid; Natsuo Ueda
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

4.  Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells.

Authors:  E V Berdyshev; P C Schmid; Z Dong; H H Schmid
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

5.  Anandamide and other N-acylethanolamines in human tumors.

Authors:  Patricia C Schmid; Lester E Wold; Randy J Krebsbach; Evgueni V Berdyshev; Harald H O Schmid
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

6.  Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice.

Authors:  Courtney D Netherland; Theresa G Pickle; Alicia Bales; Douglas P Thewke
Journal:  Atherosclerosis       Date:  2010-08-19       Impact factor: 5.162

7.  Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.

Authors:  V E Mendizábal; E Adler-Graschinsky
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

8.  Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.

Authors:  Halikhedkar Aneetha; David K O'Dell; Bo Tan; J Michael Walker; Thomas D Hurley
Journal:  Bioorg Med Chem Lett       Date:  2008-11-01       Impact factor: 2.823

9.  The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line.

Authors:  R Scott Duncan; Kent D Chapman; Peter Koulen
Journal:  Mol Neurodegener       Date:  2009-12-10       Impact factor: 14.195

Review 10.  The Interplay between the Immune and the Endocannabinoid Systems in Cancer.

Authors:  Mariantonia Braile; Simone Marcella; Gianni Marone; Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.